Metabolomics

Dataset Information

0

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival


ABSTRACT:

The spread of cancer to bone is invariably fatal, with complex cross-talk between tumor cells and the bone microenvironment responsible for driving disease progression. By combining in silico analysis of patient datasets with metabolomic profiling of prostate cancer cells cultured with bone cells, we demonstrate the changing energy requirements of prostate cancer cells in the bone microenvironment, identifying the pentose phosphate pathway (PPP) as elevated in prostate cancer bone metastasis, with increased expression of the PPP rate-limiting enzyme glucose-6-phosphate dehydrogenase (G6PD) associated with a reduction in progression-free survival. Genetic and pharmacologic manipulation demonstrates that G6PD inhibition reduces prostate cancer growth and migration, associated with changes in cellular redox state and increased chemosensitivity. Genetic blockade of G6PD in vivo results in reduction of tumor growth within bone. In summary, we demonstrate the metabolic plasticity of prostate cancer cells in the bone microenvironment, identifying the PPP and G6PD as metabolic targets for the treatment of prostate cancer bone metastasis.

INSTRUMENT(S): Capillary electrophoresis MS - positive, Capillary electrophoresis MS - negative

PROVIDER: MTBLS3973 | MetaboLights | 2024-08-19

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
info.xml Xml
Contents.xml Xml
DefaultMassCal.xml Xml
Devices.xml Xml
MSActualDefs.xml Xml
Items per page:
1 - 5 of 300
altmetric image

Publications

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.

Whitburn Jessica J   Rao Srinivasa R SR   Morris Emma V EV   Tabata Sho S   Hirayama Akiyoshi A   Soga Tomoyoshi T   Edwards James R JR   Kaya Zeynep Z   Palmer Charlotte C   Hamdy Freddie C FC   Edwards Claire M CM  

Science advances 20220225 8


The spread of cancer to bone is invariably fatal, with complex cross-talk between tumor cells and the bone microenvironment responsible for driving disease progression. By combining in silico analysis of patient datasets with metabolomic profiling of prostate cancer cells cultured with bone cells, we demonstrate the changing energy requirements of prostate cancer cells in the bone microenvironment, identifying the pentose phosphate pathway (PPP) as elevated in prostate cancer bone metastasis, wi  ...[more]

Similar Datasets

2022-02-25 | GSE190928 | GEO
2015-09-30 | GSE73044 | GEO
2025-12-04 | GSE245125 | GEO
2024-09-02 | BIOMD0000000793 | BioModels
2024-09-02 | BIOMD0000000795 | BioModels
2017-08-30 | PXD006252 | Pride
2023-09-26 | GSE210729 | GEO
2024-02-22 | GSE253815 | GEO
2023-01-29 | GSE156427 | GEO
| PRJNA945423 | ENA